Minerva Neurosciences, Inc.
NERV
Revenue
0.00
0.000.00%
3 Months ChangeAssets
46.29M
▼-4.22M▼-8.35%
3 Months ChangeLiabilities
90.78M
▲3.68M▲4.23%
3 Months ChangeFree Cash Flow
-24.66M
▼-27.70M▼-911.11%
60 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-11
Form 8-K
ID: 0001193125-24-236726
2024-09-16
Form 8-K
ID: 0001193125-24-219590
2024-08-06
Form 10-Q
ID: 0000950170-24-091195
2024-05-30
Form 8-K
ID: 0001193125-24-150357
2024-05-01
Form 10-Q
ID: 0000950170-24-050883
2024-04-12
Form 8-K
ID: 0001193125-24-094620
2024-02-27
Form 8-K
ID: 0001193125-24-047110
2023-11-07
Form 10-Q
ID: 0000950170-23-059747
2023-09-28
Form 8-K
ID: 0001193125-23-245615
2023-08-01
Form 10-Q
ID: 0000950170-23-036159